Global & Public Health (all articles) | Page 115 of 252 | Links Medicus Content Curation & Alerts in Medicine

WHO Global tuberculosis report 2020

15 Oct, 2020 | 09:35h | UTC

Global tuberculosis report 2020 – World Health Organization

News release: WHO: Global TB progress at risk – World Health Organization

Executive summary: Global tuberculosis report 2020

Commentary: WHO warns of COVID impact on TB services – CIDRAP

Commentary on Twitter

The 🌏🌍🌏 has made steady progress in tackling tuberculosis (TB), with a 1⃣4⃣% drop in deaths between 2015 and 2019.

🚨 #COVID19 will lead to setbacks if no action is taken urgently, according to 🆕 WHO report 👉https://t.co/5BvbGjaudU pic.twitter.com/A4edYfyOBH

— World Health Organization (WHO) (@WHO) October 14, 2020

Cluster randomized trial: Incentive programs for smoking cessation

15 Oct, 2020 | 09:09h | UTC

Incentive programmes for smoking cessation: cluster randomized trial in workplaces in Thailand – The BMJ

Commentary: Incentive-based smoking cessation programs could work in hard-to-reach pockets of smokers across the developing world – University of California San Francisco

Commentary on Twitter

NEW paper @bmj_latest: #RCT of multiple incentive types for #smoking cessation in worksites in Thailand (SMILE trial). Large individual bonus most effective. https://t.co/CNdvhOo7Sb

With @WilliamHDow @c_lowenstein @UCBerkeleySPH and Aree Jampklay, Nucharee Srivirojana @MahidolU pic.twitter.com/q9B61wyzrf

— Justin White (@justinswhite) October 14, 2020

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 Recommendations of the International Antiviral Society–USA Panel

15 Oct, 2020 | 09:13h | UTC

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel – JAMA

Commentary on Twitter

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults https://t.co/J3zHm9rpkY via @JAMA_current The new @IAS_USA ART guidelines document is out. Enormous effort led by @msaagmd with @RMKGandhi @doc_in_a_box @drmt @PaulSaxMD @joseph_eron and others on panel.

— Carlos del Rio (@CarlosdelRio7) October 14, 2020

Five things clinicians and patients should question in public health

15 Oct, 2020 | 09:05h | UTC

Five Things Clinicians and Patients Should Question – Choosing Wisely Canada

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

Study: Polypharmacy (taking > 10 medications) is common in older patients with heart failure

15 Oct, 2020 | 09:03h | UTC

Polypharmacy in Older Adults Hospitalized for Heart Failure – Circulation: Heart Failure

Commentaries: Ten or more medications, often prescribed to older heart failure patients, raises concerns – American Heart Association AND Polypharmacy Common Among Older Heart Failure Patients – Physician’s Weekly

Commentary on Twitter

New work from @OzanUnluMD @ParagGoyalMD indicates that polypharmacy (taking > 10 medications) is common in older patients with #heartfailure, and is primarily due to non-cardiovascular meds #AHAJournals @WeillCornell | https://t.co/hL0GZLaCnT pic.twitter.com/BHppxDQgor

— Circ: Heart Failure (@CircHF) October 13, 2020

Genomic evidence for reinfection with SARS-CoV-2: A case study

14 Oct, 2020 | 09:39h | UTC

Genomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases

Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get reinfected with Covid-19 but still have immunity. Let’s explain. – Vox AND A 25-Year-Old Nevada Man Got COVID-19 Twice. Here’s What We Know—and Don’t Know—About Reinfection – TIME

Updated NIH COVID-19 Treatment Guidelines

14 Oct, 2020 | 09:41h | UTC

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health

See also: What’s New in the Guidelines

COVID-19 in New Zealand and the impact of the national response: A descriptive epidemiological study

14 Oct, 2020 | 09:38h | UTC

COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study – The Lancet Global Health

Commentary: Lessons from New Zealand’s COVID-19 outbreak response – The Global Health

Commentary on Twitter

How New Zealand crushed covid: rapid, aggressive use of masks, distancing, testing, isolation, travel ban. Hard work.
Transmission chains notable (wedding, school clusters)https://t.co/FMCgQOsVYJ https://t.co/svRZyjvOf2 @AlxsRobert @TheLancetPH 🇳🇿👏👏 pic.twitter.com/WqxAySjqJy

— Eric Topol (@EricTopol) October 14, 2020

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

14 Oct, 2020 | 09:31h | UTC

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT

News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials

Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – Health Policy Watch AND Johnson & Johnson pauses Covid-19 vaccine trial after ‘unexplained illness’ – CNN

Non-respiratory presentations of COVID-19, a clinical review

14 Oct, 2020 | 09:33h | UTC

Non-respiratory presentations of COVID-19, a clinical review – The American Journal of Emergency Medicine

Monoclonal antibody trial halted for safety concern

14 Oct, 2020 | 09:30h | UTC

Monoclonal Antibody Trial Halted for Safety Concern – Brief19

Covid-19: how to prioritize worse-off populations in allocating safe and effective vaccines

14 Oct, 2020 | 09:25h | UTC

Covid-19: how to prioritize worse-off populations in allocating safe and effective vaccines – The BMJ

COVID-19 will probably become endemic – here’s what that means

14 Oct, 2020 | 09:27h | UTC

COVID-19 will probably become endemic – here’s what that means – The Conversation

[Abstract Only] Randomized trials: Efficacy and safety of a plant-derived influenza vaccine in adults

14 Oct, 2020 | 09:23h | UTC

Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials – The Lancet (link to abstract – $ for full-text)

Commentary on Twitter

NEW—First large-scale studies of plant-derived, quadrivalent, virus-like particle influenza vaccine show substantial protection against respiratory illness & influenza-like illness caused by influenza viruses in adults: two randomised phase 3 trials https://t.co/oQbs2uJTXY pic.twitter.com/C6b6Qi6qZ7

— The Lancet (@TheLancet) October 13, 2020

Meta-analysis: Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension

14 Oct, 2020 | 09:20h | UTC

Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension – Journal of the American Heart Association

Commentary on Twitter

Which lifestyle intervention works best for hypertension? #Bayesian meta-analysis suggests the #DASH diet https://t.co/1CgLVwN4LB #AHAJournals @tinauchojo pic.twitter.com/wzJ87OPT0m

— JAHA (@JAHA_AHA) October 5, 2020